Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study
In order to characterize pneumococcal endovascular infection in the post-vaccination era, a retrospective nationwide study based on the Israeli Adult IPD database was conducted. Between 2010 and 2019, 0.6% (23 cases) of IPD cases were of endovascular type, occurring mainly in males (72.3%) with unde...
Gespeichert in:
| Veröffentlicht in: | European journal of clinical microbiology & infectious diseases 2022-11, Vol.41 (11), p.1365-1370 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1370 |
|---|---|
| container_issue | 11 |
| container_start_page | 1365 |
| container_title | European journal of clinical microbiology & infectious diseases |
| container_volume | 41 |
| creator | Kenig, Ariel Oster, Yonatan Cohen-Poradosu, Ronit Reisenberg, Klaris Wieder-Finesod, Anat Hershman-Sarafov, Mirit Oren, Ilana Weber, Gabriel Dagan, Ron Regev-Yochay, Gili Strahilevitz, Jacob |
| description | In order to characterize pneumococcal endovascular infection in the post-vaccination era, a retrospective nationwide study based on the Israeli Adult IPD database was conducted. Between 2010 and 2019, 0.6% (23 cases) of IPD cases were of endovascular type, occurring mainly in males (72.3%) with underlying medical conditions (78.2%). Additional pneumococcal source (10 patients) and concomitant infections were not uncommon. Penicillin and ceftriaxone susceptibility rates were 65.2% and 91.3%, respectively; 60.9% of the isolates were not covered by the pneumococcal conjugate vaccine. 21.7% of patients died during hospitalization. In conclusion, pneumococcal endovascular infections still carry significant morbidity and mortality. |
| doi_str_mv | 10.1007/s10096-022-04500-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2720426046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2720426046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-3e76f8864bb2d33ae00706654b9a44c7dc15f6827136b0cd5102a137f18214343</originalsourceid><addsrcrecordid>eNp9kE1LxDAURYMoOI7-AVcFN26iLx9NOriSwS8YcKPrkKapZugkY9LO4L83tYLgwk3CC-c8bi5C5wSuCIC8TvlcCAyUYuAlAN4foBnhrMScSXaIZrBgHC8kZcfoJKU1ZKmScobq5buO2vQ2utQ7k4rQFtY3YaeTGTodi623wyaYYIzuCudba3oXfLopdNFYoxs7Gl6Pj3uXpzTEnXVdp73JQz80n6foqNVdsmc_9xy93t-9LB_x6vnhaXm7woZWtMfMStFWleB1TRvGtM0RQYiS1wvNuZGNIWUrKioJEzWYpiRANWGyJRXNP-Vsji6nvdsYPgaberVxydgxig1DUlRS4FQAFxm9-IOuwxB9TjdSHGQpKMkUnSgTQ0rRtmob3UbHT0VAjbWrqXaVa1fftat9ltgkpQz7Nxt_V_9jfQF_RIXQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2724075621</pqid></control><display><type>article</type><title>Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study</title><source>Springer Nature - Complete Springer Journals</source><creator>Kenig, Ariel ; Oster, Yonatan ; Cohen-Poradosu, Ronit ; Reisenberg, Klaris ; Wieder-Finesod, Anat ; Hershman-Sarafov, Mirit ; Oren, Ilana ; Weber, Gabriel ; Dagan, Ron ; Regev-Yochay, Gili ; Strahilevitz, Jacob</creator><creatorcontrib>Kenig, Ariel ; Oster, Yonatan ; Cohen-Poradosu, Ronit ; Reisenberg, Klaris ; Wieder-Finesod, Anat ; Hershman-Sarafov, Mirit ; Oren, Ilana ; Weber, Gabriel ; Dagan, Ron ; Regev-Yochay, Gili ; Strahilevitz, Jacob</creatorcontrib><description>In order to characterize pneumococcal endovascular infection in the post-vaccination era, a retrospective nationwide study based on the Israeli Adult IPD database was conducted. Between 2010 and 2019, 0.6% (23 cases) of IPD cases were of endovascular type, occurring mainly in males (72.3%) with underlying medical conditions (78.2%). Additional pneumococcal source (10 patients) and concomitant infections were not uncommon. Penicillin and ceftriaxone susceptibility rates were 65.2% and 91.3%, respectively; 60.9% of the isolates were not covered by the pneumococcal conjugate vaccine. 21.7% of patients died during hospitalization. In conclusion, pneumococcal endovascular infections still carry significant morbidity and mortality.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-022-04500-w</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antibiotics ; Biomedical and Life Sciences ; Biomedicine ; Brief Report ; Cardiovascular system ; Ceftriaxone ; Endocarditis ; Health maintenance organizations ; Heart failure ; HMOs ; Immunization ; Infectious diseases ; Internal Medicine ; Laboratories ; Long term health care ; Medical Microbiology ; Medicine ; Meningitis ; Microbiology ; Morbidity ; Mortality ; Patients ; Penicillin ; Pneumonia ; Streptococcus infections ; Vaccination ; Vaccines</subject><ispartof>European journal of clinical microbiology & infectious diseases, 2022-11, Vol.41 (11), p.1365-1370</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c282t-3e76f8864bb2d33ae00706654b9a44c7dc15f6827136b0cd5102a137f18214343</citedby><cites>FETCH-LOGICAL-c282t-3e76f8864bb2d33ae00706654b9a44c7dc15f6827136b0cd5102a137f18214343</cites><orcidid>0000-0002-9192-7164</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10096-022-04500-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10096-022-04500-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids></links><search><creatorcontrib>Kenig, Ariel</creatorcontrib><creatorcontrib>Oster, Yonatan</creatorcontrib><creatorcontrib>Cohen-Poradosu, Ronit</creatorcontrib><creatorcontrib>Reisenberg, Klaris</creatorcontrib><creatorcontrib>Wieder-Finesod, Anat</creatorcontrib><creatorcontrib>Hershman-Sarafov, Mirit</creatorcontrib><creatorcontrib>Oren, Ilana</creatorcontrib><creatorcontrib>Weber, Gabriel</creatorcontrib><creatorcontrib>Dagan, Ron</creatorcontrib><creatorcontrib>Regev-Yochay, Gili</creatorcontrib><creatorcontrib>Strahilevitz, Jacob</creatorcontrib><title>Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study</title><title>European journal of clinical microbiology & infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>In order to characterize pneumococcal endovascular infection in the post-vaccination era, a retrospective nationwide study based on the Israeli Adult IPD database was conducted. Between 2010 and 2019, 0.6% (23 cases) of IPD cases were of endovascular type, occurring mainly in males (72.3%) with underlying medical conditions (78.2%). Additional pneumococcal source (10 patients) and concomitant infections were not uncommon. Penicillin and ceftriaxone susceptibility rates were 65.2% and 91.3%, respectively; 60.9% of the isolates were not covered by the pneumococcal conjugate vaccine. 21.7% of patients died during hospitalization. In conclusion, pneumococcal endovascular infections still carry significant morbidity and mortality.</description><subject>Antibiotics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brief Report</subject><subject>Cardiovascular system</subject><subject>Ceftriaxone</subject><subject>Endocarditis</subject><subject>Health maintenance organizations</subject><subject>Heart failure</subject><subject>HMOs</subject><subject>Immunization</subject><subject>Infectious diseases</subject><subject>Internal Medicine</subject><subject>Laboratories</subject><subject>Long term health care</subject><subject>Medical Microbiology</subject><subject>Medicine</subject><subject>Meningitis</subject><subject>Microbiology</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Patients</subject><subject>Penicillin</subject><subject>Pneumonia</subject><subject>Streptococcus infections</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kE1LxDAURYMoOI7-AVcFN26iLx9NOriSwS8YcKPrkKapZugkY9LO4L83tYLgwk3CC-c8bi5C5wSuCIC8TvlcCAyUYuAlAN4foBnhrMScSXaIZrBgHC8kZcfoJKU1ZKmScobq5buO2vQ2utQ7k4rQFtY3YaeTGTodi623wyaYYIzuCudba3oXfLopdNFYoxs7Gl6Pj3uXpzTEnXVdp73JQz80n6foqNVdsmc_9xy93t-9LB_x6vnhaXm7woZWtMfMStFWleB1TRvGtM0RQYiS1wvNuZGNIWUrKioJEzWYpiRANWGyJRXNP-Vsji6nvdsYPgaberVxydgxig1DUlRS4FQAFxm9-IOuwxB9TjdSHGQpKMkUnSgTQ0rRtmob3UbHT0VAjbWrqXaVa1fftat9ltgkpQz7Nxt_V_9jfQF_RIXQ</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Kenig, Ariel</creator><creator>Oster, Yonatan</creator><creator>Cohen-Poradosu, Ronit</creator><creator>Reisenberg, Klaris</creator><creator>Wieder-Finesod, Anat</creator><creator>Hershman-Sarafov, Mirit</creator><creator>Oren, Ilana</creator><creator>Weber, Gabriel</creator><creator>Dagan, Ron</creator><creator>Regev-Yochay, Gili</creator><creator>Strahilevitz, Jacob</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9192-7164</orcidid></search><sort><creationdate>20221101</creationdate><title>Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study</title><author>Kenig, Ariel ; Oster, Yonatan ; Cohen-Poradosu, Ronit ; Reisenberg, Klaris ; Wieder-Finesod, Anat ; Hershman-Sarafov, Mirit ; Oren, Ilana ; Weber, Gabriel ; Dagan, Ron ; Regev-Yochay, Gili ; Strahilevitz, Jacob</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-3e76f8864bb2d33ae00706654b9a44c7dc15f6827136b0cd5102a137f18214343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibiotics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brief Report</topic><topic>Cardiovascular system</topic><topic>Ceftriaxone</topic><topic>Endocarditis</topic><topic>Health maintenance organizations</topic><topic>Heart failure</topic><topic>HMOs</topic><topic>Immunization</topic><topic>Infectious diseases</topic><topic>Internal Medicine</topic><topic>Laboratories</topic><topic>Long term health care</topic><topic>Medical Microbiology</topic><topic>Medicine</topic><topic>Meningitis</topic><topic>Microbiology</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Patients</topic><topic>Penicillin</topic><topic>Pneumonia</topic><topic>Streptococcus infections</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kenig, Ariel</creatorcontrib><creatorcontrib>Oster, Yonatan</creatorcontrib><creatorcontrib>Cohen-Poradosu, Ronit</creatorcontrib><creatorcontrib>Reisenberg, Klaris</creatorcontrib><creatorcontrib>Wieder-Finesod, Anat</creatorcontrib><creatorcontrib>Hershman-Sarafov, Mirit</creatorcontrib><creatorcontrib>Oren, Ilana</creatorcontrib><creatorcontrib>Weber, Gabriel</creatorcontrib><creatorcontrib>Dagan, Ron</creatorcontrib><creatorcontrib>Regev-Yochay, Gili</creatorcontrib><creatorcontrib>Strahilevitz, Jacob</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology & infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kenig, Ariel</au><au>Oster, Yonatan</au><au>Cohen-Poradosu, Ronit</au><au>Reisenberg, Klaris</au><au>Wieder-Finesod, Anat</au><au>Hershman-Sarafov, Mirit</au><au>Oren, Ilana</au><au>Weber, Gabriel</au><au>Dagan, Ron</au><au>Regev-Yochay, Gili</au><au>Strahilevitz, Jacob</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study</atitle><jtitle>European journal of clinical microbiology & infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><date>2022-11-01</date><risdate>2022</risdate><volume>41</volume><issue>11</issue><spage>1365</spage><epage>1370</epage><pages>1365-1370</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>In order to characterize pneumococcal endovascular infection in the post-vaccination era, a retrospective nationwide study based on the Israeli Adult IPD database was conducted. Between 2010 and 2019, 0.6% (23 cases) of IPD cases were of endovascular type, occurring mainly in males (72.3%) with underlying medical conditions (78.2%). Additional pneumococcal source (10 patients) and concomitant infections were not uncommon. Penicillin and ceftriaxone susceptibility rates were 65.2% and 91.3%, respectively; 60.9% of the isolates were not covered by the pneumococcal conjugate vaccine. 21.7% of patients died during hospitalization. In conclusion, pneumococcal endovascular infections still carry significant morbidity and mortality.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s10096-022-04500-w</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-9192-7164</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0934-9723 |
| ispartof | European journal of clinical microbiology & infectious diseases, 2022-11, Vol.41 (11), p.1365-1370 |
| issn | 0934-9723 1435-4373 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2720426046 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Antibiotics Biomedical and Life Sciences Biomedicine Brief Report Cardiovascular system Ceftriaxone Endocarditis Health maintenance organizations Heart failure HMOs Immunization Infectious diseases Internal Medicine Laboratories Long term health care Medical Microbiology Medicine Meningitis Microbiology Morbidity Mortality Patients Penicillin Pneumonia Streptococcus infections Vaccination Vaccines |
| title | Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T19%3A41%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20of%20endovascular%20pneumococcal%20infections;%20a%20decade%20of%20nationwide%20surveillance%20study&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Kenig,%20Ariel&rft.date=2022-11-01&rft.volume=41&rft.issue=11&rft.spage=1365&rft.epage=1370&rft.pages=1365-1370&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-022-04500-w&rft_dat=%3Cproquest_cross%3E2720426046%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2724075621&rft_id=info:pmid/&rfr_iscdi=true |